Johns Hopkins startup could help detect ovarian cancer

By the time ovarian cancer is diagnosed in most women, it's difficult — if not impossible — to eliminate.

This cancer has few early symptoms and there is no test to detect it in its earliest stages. Of the 70,000 women diagnosed with cervical cancer every year, about a third die.

Johns Hopkins startup PapGene thinks it has an answer.

The startup is developing a way to detect ovarian and endometiral cancers through a test similar to a pap smear, the common minimally invasive test gynecologists…

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2015 Category: Pharmaceuticals Authors: Sarah Gantz Source Type: news